IDH2 and astrocytoma (excluding glioblastoma): We also analyzed an independent group of 12 IDH-mutant astrocytomas and 18 IDH-wild-type glioblastomas which were wild-type for MMR genes at the first resection but developed an MMR mutation at tumor recurrence.